Latest & greatest articles for fibromyalgia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on fibromyalgia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on fibromyalgia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for fibromyalgia

61. Treatments for Fibromyalgia in Adult Subgroups

Treatments for Fibromyalgia in Adult Subgroups Treatments for Fibromyalgia in Adult Subgroups Treatments for Fibromyalgia in Adult Subgroups Forte ML, Butler M, Andrade KE, Vincent A, Schousboe JT, Kane RL Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Forte ML, Butler M, Andrade KE, Vincent A, Schousboe JT, Kane RL. Treatments (...) for Fibromyalgia in Adult Subgroups. Rockville: Agency for Healthcare Research and Quality (AHRQ). Comparative Effectiveness Review No. 148. 2015 Authors' objectives We searched MEDLINE, EMBASE, PsycINFO, AMED, and the Cochrane Central Register of Controlled Trials (CENTRAL) plus reference lists of included studies and recent systematic reviews. Authors' conclusions Despite the prevalent belief that fibromyalgia treatments may behave differently in subgroups, evidence to date is largely insufficient

2015 Health Technology Assessment (HTA) Database.

62. Treatments for Fibromyalgia in Adult Subgroups

treatment outcomes in at least one subgroup 3 months or more after the initiation of treatment. We excluded studies of drugs not FDA approved in the United States for any condition; studies that included patients with different health conditions and that did not separately report baseline and outcomes in fibromyalgia patients; studies that did not use established fibromyalgia diagnostic criteria for subject selection (ACR 11-13 or Yunus 41 criteria for fibrositis from 1985-90); and pharmaceutical RCTs (...) Treatments for Fibromyalgia in Adult Subgroups Treatments for Fibromyalgia in Adult Subgroups Comparative Effectiveness Review Number 148Comparative Effectiveness Review Number 148 Treatments for Fibromyalgia in Adult Subgroups Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov Contract No. 290-2012-00016-I Prepared by: Minnesota Evidence-based Practice Center Minneapolis, MN Investigators: Mary

2015 Effective Health Care Program (AHRQ)

63. Effects of cranial electrical stimulation on activity in regions of the basal ganglia in individuals with fibromyalgia. (Abstract)

Effects of cranial electrical stimulation on activity in regions of the basal ganglia in individuals with fibromyalgia. 24571578 2014 11 07 2014 03 06 1557-7708 20 3 2014 Mar Journal of alternative and complementary medicine (New York, N.Y.) J Altern Complement Med Effects of cranial electrical stimulation on activity in regions of the basal ganglia in individuals with fibromyalgia. 206-7 10.1089/acm.2014.1501 Anderson Joel G JG 1 Center for the Study of Complementary and Alternative Therapies (...) , University of Virginia , Charlottesville, VA. Kebaish Samy A SA Lewis Janet E JE Taylor Ann Gill AG eng Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't 2014 02 26 United States J Altern Complement Med 9508124 1075-5535 IM Basal Ganglia physiopathology Electric Stimulation Therapy methods Fibromyalgia physiopathology therapy Humans Magnetic Resonance Imaging 2014 2 28 6 0 2014 2 28 6 0 2014 11 8 6 0 ppublish 24571578 10.1089/acm.2014.1501

2014 Journal of alternative and complementary medicine (New York, N.Y.) Controlled trial quality: uncertain

64. Efficacy of memantine in the treatment of fibromyalgia: A double-blind, randomised, controlled trial with 6-month follow-up (Abstract)

Efficacy of memantine in the treatment of fibromyalgia: A double-blind, randomised, controlled trial with 6-month follow-up Fibromyalgia (FM) is a prevalent and disabling chronic disease. Recent studies have found elevated levels of glutamate in several brain regions, leading to hypotheses about the usefulness of glutamate-blocking drugs such as memantine in the treatment of FM. The aim of this study was to evaluate the efficacy of memantine in the treatment of pain and other clinical variables

2014 EvidenceUpdates Controlled trial quality: predicted high

65. Antiepileptic drugs for neuropathic pain and fibromyalgia. (Abstract)

Antiepileptic drugs for neuropathic pain and fibromyalgia. Are antiepileptic drugs associated with reduced pain intensity in patients with neuropathic pain or fibromyalgia?In treating diabetic neuropathy and postherpetic neuralgia compared with placebo, gabapentin and pregabalin are associated with a modest increase in the number of patients experiencing meaningful pain reduction. In treating fibromyalgia, compared with placebo, pregabalin alone is associated with a small increase in the number

2014 JAMA

66. Fibromyalgia: a clinical review. Full Text available with Trip Pro

Fibromyalgia: a clinical review. Fibromyalgia is present in as much as 2% to 8% of the population, is characterized by widespread pain, and is often accompanied by fatigue, memory problems, and sleep disturbances.To review the epidemiology, pathophysiology, diagnosis, and treatment of fibromyalgia.The medical literature on fibromyalgia was reviewed from 1955 to March 2014 via MEDLINE and the Cochrane Central Registry of Controlled Trials, with an emphasis on meta-analyses and contemporary (...) evidence-based treatment guidelines. Treatment recommendations are based on the most recent evidence-based guidelines from the Canadian Pain Society and graded from 1 to 5 based on the level of available evidence.Numerous treatments are available for managing fibromyalgia that are supported by high-quality evidence. These include nonpharmacological therapies (education, exercise, cognitive behavioral therapy) and pharmacological therapies (tricyclics, serotonin norepinephrine reuptake inhibitors

2014 JAMA

67. Fibromyalgia

Fibromyalgia Diagnostic challenges 690 REPRINTED FROM AUSTRALIAN FAMILY PHYSICIAN VOL. 42, NO. 10 OCTOBER 2013 Fibromyalgia Background Fibromyalgia is a common and debilitating condition. The cardinal feature of fibromyalgia is musculoskeletal pain, usually accompanied by other problems, such as fatigue, sleep disturbance and cognitive difficulties. Fibromyalgia commonly coexists with other chronic illnesses and can result in poorer outcomes if untreated. Objective The objective of this review (...) is to discuss when fibromyalgia should be considered as a diagnosis, how it is diagnosed, the current understanding of the pathophysiology of fibromyalgia and the management strategies available. Discussion The features of fibromyalgia are similar to those of many other chronic illnesses, sometimes resulting in diagnostic confusion. Fibromyalgia can co-exist with other disorders and it is important to consider the possibility of fibromyalgia contributing to symptoms in any chronically ill patient. Keywords

2014 Clinical Practice Guidelines Portal

68. The Spanish version of the Fibromyalgia Rapid Screening Tool: translation, validity and reliability Full Text available with Trip Pro

The Spanish version of the Fibromyalgia Rapid Screening Tool: translation, validity and reliability Despite showing acceptable psychometric properties, the criterion validity of the original Fibromyalgia Rapid Screening Tool (FiRST) has been called into question for including insufficiently challenging comparison groups. Consequently our objective was to validate a Spanish version of the FiRST including pain disorders more analogous to fibromyalgia.The FiRST was translated following (...) international standards. Internal consistency and temporal stability were assessed. The ability of the FiRST global score as a screening tool for fibromyalgia (criterion validity) was assessed by logistic regression analysis. To determine the degree to which potential confounders might affect the criterion validity of the FiRST (divergent validity), it was reassessed by hierarchical multivariate logistic regression, entering demographics in a first step, followed by pain, anxiety and depression

2014 EvidenceUpdates

69. Multi-Component Cognitive Behavioral Therapy for Fibromyalgia

Multi-Component Cognitive Behavioral Therapy for Fibromyalgia Multi-Component Cognitive Behavioral Therapy for Fibromyalgia – Society of Clinical Psychology Description Cognitive Behavioral Therapy (CBT) for FM can be tailored to target many of the symptom domains associated with FM. CBT emphasizes the learning of adaptive behavioral responses to illness and in so doing, alters thinking styles, experiences, and emotional responses that can maintain or worsen the illness. Given FM (...) change promoting skills targeting barriers to change, unhelpful thinking styles, and long term maintenance of change (e.g. stress management, goal setting, structured problem solving, reframing, and communication skills). In order to better learn and integrate skills into one’s life style, CBT relies upon self-monitoring, skill rehearsal, and social reinforcement. CBT for fibromyalgia can be administered either individually or in small groups over 6 to 10 sessions. Key References (in reverse

2014 Society of Clinical Psychology

70. Acupuncture may be effective for fibromyalgia

Acupuncture may be effective for fibromyalgia Acupuncture may be effective for fibromyalgia | Cochrane Primary Care Trusted evidence. Informed decisions. Better health. Enter terms Acupuncture may be effective for fibromyalgia Cochrane Trusted evidence. Informed decisions. Better health. Copyright © 2019 The Cochrane Collaboration | | We use cookies to improve your experience on our site.

2013 Cochrane PEARLS

71. Limited evidence for benefit of amitriptyline for neuropathic pain and fibromyalgia in adults

Limited evidence for benefit of amitriptyline for neuropathic pain and fibromyalgia in adults Limited evidence for benefit of amitriptyline for neuropathic pain and fibromyalgia in adults | Cochrane Primary Care Trusted evidence. Informed decisions. Better health. Enter terms Limited evidence for benefit of amitriptyline for neuropathic pain and fibromyalgia in adults Cochrane Trusted evidence. Informed decisions. Better health. Copyright © 2019 The Cochrane Collaboration | | We use cookies

2013 Cochrane PEARLS

72. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia Full Text available with Trip Pro

Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia Because transcutaneous electrical nerve stimulation (TENS) works by reducing central excitability and activating central inhibition pathways, we tested the hypothesis that TENS would reduce pain and fatigue and improve function and hyperalgesia in people with fibromyalgia who have enhanced central excitability and reduced inhibition. The current study (...) used a double-blinded randomized, placebo-controlled cross-over design to test the effects of a single treatment of TENS with people with fibromyalgia. Three treatments were assessed in random order: active TENS, placebo TENS and no TENS. The following measures were assessed before and after each TENS treatment: pain and fatigue at rest and in movement; pressure pain thresholds, 6-m walk test, range of motion; 5-time sit-to-stand test, and single-leg stance. Conditioned pain modulation

2013 EvidenceUpdates Controlled trial quality: uncertain

73. Randomised controlled trial: Telephone-based cognitive-behavioural therapy and a structured exercise programme are effective for chronic widespread pain (fibromyalgia)

Randomised controlled trial: Telephone-based cognitive-behavioural therapy and a structured exercise programme are effective for chronic widespread pain (fibromyalgia) Telephone-based cognitive-behavioural therapy and a structured exercise programme are effective for chronic widespread pain (fibromyalgia) | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn (...) are effective for chronic widespread pain (fibromyalgia) Article Text Therapeutics Randomised controlled trial Telephone-based cognitive-behavioural therapy and a structured exercise programme are effective for chronic widespread pain (fibromyalgia) Kurt Kroenke Correspondence to : Kurt Kroenke Indiana University School of Medicine, 1050 Wishard Blvd, Regenstrief Institute, 5th Floor, Indianapolis, Indiana 46202, USA; kkroenke{at}regenstrief.org Statistics from Altmetric.com Commentary on: McBeth J

2013 Evidence-Based Medicine

74. Small benefit from cognitive behavioural therapies for fibromyalgia

Small benefit from cognitive behavioural therapies for fibromyalgia Small benefit from cognitive behavioural therapies for fibromyalgia | Cochrane Primary Care Trusted evidence. Informed decisions. Better health. Enter terms Small benefit from cognitive behavioural therapies for fibromyalgia Cochrane Trusted evidence. Informed decisions. Better health. Copyright © 2019 The Cochrane Collaboration | | We use cookies to improve your experience on our site.

2013 Cochrane PEARLS

75. The cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective Full Text available with Trip Pro

The cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective The cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective The cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective Lloyd A, Boomershine CS, Choy EH, Chandran A, Zlateva G Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results (...) and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The study examined the cost-effectiveness of pregabalin for treatment of severe fibromyalgia compared with placebo, duloxetine, milnacipran, gabapentin, tramadol and amitriptyline. The authors concluded that pregabalin was more beneficial and less expensive than the other available treatments for severe fibromyalgia, except when compared to amitriptyline. The study used valid

2012 NHS Economic Evaluation Database.

76. Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: a randomized, placebo-controlled, 2-way crossover polysomnography study (Abstract)

Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: a randomized, placebo-controlled, 2-way crossover polysomnography study To assess the effect of pregabalin on polysomnographic (PSG) measures of sleep and patient-rated sleep, tiredness, and pain in fibromyalgia patients.We performed a randomized, double-blind, placebo-controlled, 2-period crossover PSG study. Patients ages ≥18 years with fibromyalgia satisfied subjective and objective sleep (...) score improved (decreased) with pregabalin versus placebo treatment at all 4 weeks (week 4 difference: -0.52 [95% CI -0.90, -0.14]; P = 0.0084). Modest (ρ = <0.3) but significant correlations were found between PSG sleep assessments and ratings of pain and sleep quality. Frequently reported all-causality adverse events (pregabalin versus placebo) were: dizziness (30.4% versus 9.9%), somnolence (20.5% versus 4.5%), and headache (8.9% versus 8.1%).Patients with fibromyalgia treated with pregabalin had

2012 EvidenceUpdates Controlled trial quality: predicted high

77. Phenytoin for neuropathic pain and fibromyalgia in adults. Full Text available with Trip Pro

Phenytoin for neuropathic pain and fibromyalgia in adults. Antiepileptic drugs have been used in pain management since the 1960s; some have shown efficacy in treating different neuropathic pain conditions. Phenytoin is an established antiepileptic drug that has been used occasionally to treat intractable trigeminal neuralgia.To assess the analgesic efficacy and adverse effects of the antiepileptic drug phenytoin in neuropathic pain and fibromyalgia.We searched the Cochrane Central Register (...) quality.We did not identify any studies that satisfied the inclusion criteria.This review uncovered no evidence of sufficient quality to support the use of phenytoin in chronic neuropathic pain or fibromyalgia.

2012 Cochrane

78. Clonazepam for neuropathic pain and fibromyalgia in adults. Full Text available with Trip Pro

Clonazepam for neuropathic pain and fibromyalgia in adults. Antiepileptic drugs have been used in pain management since the 1960s; some have shown efficacy in treating different neuropathic pain conditions. Clonazepam, a benzodiazepine, is an established antiepileptic drug, but its place in the treatment of neuropathic pain is unclear.To assess the analgesic efficacy and adverse effects of the antiepileptic drug clonazepam in neuropathic pain and fibromyalgia.We searched the Cochrane Central (...) of study quality.We did not identify any studies that satisfied the inclusion criteria.This review uncovered no evidence of sufficient quality to support the use of clonazepam in chronic neuropathic pain or fibromyalgia.

2012 Cochrane

79. Multicomponent cognitive-behavioral group therapy with hypnosis for the treatment of fibromyalgia: long-term outcome (Abstract)

Multicomponent cognitive-behavioral group therapy with hypnosis for the treatment of fibromyalgia: long-term outcome This study compared the efficacy of 2 psychological treatments for fibromyalgia with each other and with standard care. Ninety-three patients with fibromyalgia (FM) were randomly assigned to 1 of the 3 experimental conditions: 1) multicomponent cognitive-behavioral therapy (CBT); 2) multicomponent CBT with hypnosis; and 3) pharmacological treatment (standard care control group (...) in a multicomponent cognitive-behavioral group treatment of fibromyalgia patients. Also, this research showed that by adding hypnosis the length of treatment did not increase.Copyright © 2012 American Pain Society. Published by Elsevier Inc. All rights reserved.

2012 EvidenceUpdates Controlled trial quality: uncertain

80. Cognitive behavioral therapy for the treatment of juvenile fibromyalgia: a multisite, single-blind, randomized, controlled clinical trial Full Text available with Trip Pro

Cognitive behavioral therapy for the treatment of juvenile fibromyalgia: a multisite, single-blind, randomized, controlled clinical trial Juvenile fibromyalgia syndrome (FMS) is a chronic musculoskeletal pain disorder in children and adolescents for which there are no evidence-based treatments. The objective of this multisite, single-blind, randomized clinical trial was to test whether cognitive-behavioral therapy (CBT) was superior to fibromyalgia (FM) education in reducing functional

2012 EvidenceUpdates Controlled trial quality: predicted high